Selenium-induced senescence involves heterochromatin formation
dc.contributor.advisor | Cheng, Wen-Hsing | en_US |
dc.contributor.author | Rouse, Jallah | en_US |
dc.contributor.department | Nutrition | en_US |
dc.contributor.publisher | Digital Repository at the University of Maryland | en_US |
dc.contributor.publisher | University of Maryland (College Park, Md.) | en_US |
dc.date.accessioned | 2014-02-06T06:32:37Z | |
dc.date.available | 2014-02-06T06:32:37Z | |
dc.date.issued | 2013 | en_US |
dc.description.abstract | Abstract We have recently shown that selenium compounds can induce a senescence response in a manner depending on ataxia-telangiectasia mutated (ATM), DNA-dependent protein kinase (DNA-PK), p53 and reactive oxygen species (ROS). To test the hypothesis that the selenium-induced senescence response involves epigenetic changes in senescence-associated heterochromatin foci (SAHF), we determined the expression of histone H3 Lysine 9 trimethylation (H3K9me3), a marker of SAHF, in human primary MRC-5 cells treated with methylseleninic acid (MSeA, 2 μM) for 2 days, followed by a 7-day recovery, in the presence or absence of KU55933 (10 μM), an ATM kinase inhibitor, and NU7026 (10 μM), a DNA-PK kinase inhibitor. Our results showed that MSeA treatment induced the formation of SAHF and H3K9me3 foci. Pre-treatment of the cells with KU55955 or NU7026 resulted in numerous and smaller foci, and they did not co-localize with the MSeA-induced SAHF. These results suggest that the MSeA-induced senescence response involves epigenetic changes of H3K9me3 in a manner depending on ATM and DNA-PK. | en_US |
dc.identifier.uri | http://hdl.handle.net/1903/14857 | |
dc.language.iso | en | en_US |
dc.subject.pqcontrolled | Nutrition | en_US |
dc.subject.pqcontrolled | Molecular biology | en_US |
dc.title | Selenium-induced senescence involves heterochromatin formation | en_US |
dc.type | Thesis | en_US |
Files
Original bundle
1 - 1 of 1